CollPlant Biotechnologies Ltd. logo

CollPlant Biotechnologies Ltd.

CLGN | NASDAQ
Chart Builder DCF Calculator
$4.14
-$0.16 (-3.72%)
Sep 22, 2026, 2:43 PM ET · Market open

Market Data

Market Cap
$5.58M
Enterprise Value
$3.96M
Beta
0.74
Average Volume
161.42K
Shares Outstanding (Diluted)
1.37M
Shares Change YoY
20.02%
Institutional Ownership
0.00%
Exchange
NASDAQ
ISIN
IL0004960188

Price Performance

Price Change 1M
30.3%
Price Change 3M
22.2%
Price Change 6M
-42.7%
Price Change YTD
-71.0%
Price Change 1Y
-82.7%
Price Change 3Y
-92.8%
Price Change 5Y
-97.4%
1M CAGR (ann.)
26.8%
1Y CAGR (ann.)
-83.7%
5Y CAGR (ann.)
-52.6%
All-Time CAGR
N/A

Valuation

PE Ratio
-0.42
Forward PE
140.00
PEG Ratio
-0.03
Forward PEG
0.01
PS Ratio
14.33
Forward PS
2.20
PB Ratio
1.14
P/FCF Ratio
-0.48
P/Adj. FCF Ratio
-0.45
P/OCF Ratio
-0.51
EV/Sales
10.19
EV/EBIT
-0.31
EV/EBITDA
-0.33
EV/FCF
-0.34
Earnings Yield
-239.5%
FCF Yield
-208.1%
Adj. FCF Yield
-222.8%

Financial Health

Net Cash
$4.26M
Total Debt
$2.65M
Cash & Short-Term Investments
$4.26M
Total Assets
$9.18M
Current Ratio
2.27
Quick Ratio
1.99
Debt / Equity Ratio
0.54
Debt / EBITDA
-0.22
Debt / FCF
-0.23
OCF / Debt
-4.37
Interest Coverage
-57.30
Altman Z-Score
-22.92
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
-319.3%
Operating Profit Margin
-3329.1%
EBITDA Margin
-3092.6%
Net Profit Margin
-3376.3%
FCF Margin
-2982.6%
Adj. FCF Margin
-3192.8%
SBC / Revenue
210.3%
SBC Impact (per share)
-7.0%

Returns

Return on Assets
-143.0%
Return on Equity
-160.3%
Return on Invested Capital
-171.9%
Return on Capital Employed
-192.1%
Return on Tangible Assets
-143.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
-16.4%
Revenue CAGR 5Y
-54.5%
Revenue CAGR 10Y
2.6%
EPS CAGR 3Y
-18.5%
EPS CAGR 5Y
7.4%
EPS CAGR 10Y
12.5%
FCF CAGR 3Y
-44.5%
FCF CAGR 5Y
5.4%
FCF CAGR 10Y
-14.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
5
EPS Growth Next 3Y
28.5%
Revenue Growth Next 3Y
108.0%
Earnings Date
Dec 1, 2026
EPS Estimate (next Q)
-$0.24
EPS Growth Est (next Q)
-90.9%
Revenue Est (next Q)
$480K
Revenue Growth Est (next Q)
523.4%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$12.50
Price Target Upside
190.7%

Cash Flow

Operating Cash Flow
$-11.58M
Free Cash Flow
$-11.6M
Adj. Free Cash Flow
$-12.42M
FCF Per Share
-$8.44
OCF Per Share
-$8.42
OCF/S Ratio
-2975.8%

Income Statement

Revenue
$389K
Gross Profit
$-1.24M
Operating Income
$-12.95M
EBITDA
$-12.03M
Net Income
$-13.13M
EPS (Diluted)
-$10.30
Revenue / Employee
$9.97K
Profit / Employee
$-336.77K
Employees
39

© 2026 bestshares.com. All rights reserved.